From the Press Selected items in the scientific or general press about Ruxton or related to Ruxton's approach: Science articles of note: Beta lactam Antibiotics Offer Neuroprotection by Increasing Glutamate Transporter Expression (Nature) Treating Neurodegenerative Diseases with Antibiotics (Science) Amyotrophic Lateral Sclerosis - A New Role for Old Drugs (New England Journal of Medicine) Press Releases Ruxton Pharmaceuticals, Inc. Secures $5.2 MM Series A Financing Information for Patients Here patients can find links to information on a variety of glutamate-mediated diseases We believe that slowing the progression of neurodegenerative diseases is possible - and an important goal: |
